Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
UroGen Pharma Ltd. (URGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/28/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/28/2023 4/A Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 1,030 options to buy @ $5, valued at $5.2k
02/28/2023 4/A Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 32,723 options to buy @ $5.94, valued at $194.4k
Exercised 15,276 options to buy @ $5.94, valued at $90.7k
07/12/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/12/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/09/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/09/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
10/05/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy